Overview

Update
Status
Subsidiary of TV2 Holding
IPO / Stock
Went Public on Apr 17, 2014 / NASDAQ:TRIV
Headquarters:
Santa Rosa, CA
Description:
TriVascular develops new medical devices providing optimal solutions for endovascular aortic repair (EVAR).
Founders:
, ,
Categories:
Medical Device, Health Care, Health Diagnostics
Website:
http://www.trivascular.com/
Social:

Company Details

Update
Founded:
1998
Aliases:
TriVascular Technologies, Inc., TV2 HOLDING Co
Employees:
11 in Crunchbase

TRIVASCULAR is committed to developing new medical devices that address unmet clinical needs while providing an excellent working environment for its employees. The company was founded by Michael Chobotov, Ph.D., Robert Whirley, Ph.D., and Joseph Humphrey, Ph.D. TriVascular is located 50 miles north of San Francisco in the heart of the Sonoma Wine Country. TriVascular offers excellent career opportunities, benefits and quality of life to its employees.

TRIVASCULAR's first products are next-generation transluminally placed endovascular grafts, often referred to as stent-grafts, for the treatment of aneurysmal disease in the abdominal aorta (AAA) and the thoracic aorta (TAA). Such endovascular procedures can lead to substantially lower mortality, morbidity, and cost compared to open surgical repair. TriVascular has developed a novel device design that achieves a low profile, permitting substantially improved access through the vasculature.

Funding Rounds (7) - $266.95M

Update
DateAmount / RoundValuationLead InvestorInvestors
Aug, 2015$10M / Post Ipo Debt0
Dec, 2013$1.95M / Venture0
Nov, 2013$40M / Series E9
Jun, 2012$60M / Series D7
Aug, 2010$60M / Series C5
Nov, 2009$30M / Series B4
Mar, 2008$65M / Series A4

Current Team (11)

Update

Offices/Locations (1)

Update
  • Headquarters

    3910 Brickway Blvd.

    Santa Rosa, CA 95403

    USA

Past Team (1)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos